The Lancet Rheumatology is committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy.
A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. In a clinical study, the inhibition of a specific signaling pathway ...
Jan 23, 2024
0
26
When the University of Delaware's Gregory Hicks started his research career two decades ago, he was one of only a few people in the United States studying chronic low back pain in people over 60 years old.
Dec 19, 2023
0
40
A major clinical trial, led by experts at the University of Nottingham, has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their ...
Dec 12, 2023
0
31
A category of musculoskeletal disorders of our joints, muscles, bones, ligaments, tendons, and spine are on the rise, and a new forecast is as many as 1.06 billion people—up from 464 million—will be living with related ...
Nov 20, 2023
0
6
The global burden of osteoarthritis has increased since 1990 and is projected to continue increasing, according to a study published online Aug. 21 in The Lancet Rheumatology.
Aug 22, 2023
0
0
The degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say.
Aug 22, 2023
0
15
New research involving the University of Southampton has identified which people with compromised immune systems are less likely to have COVID-19 antibodies—making them more vulnerable to a severe infection.
Aug 15, 2023
0
5
